eligibility for clinicaltrials:NCT00005993 [clinicaltrials_resource:3f0006d02d5a59956b2eb8fec647fedf]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00005993 [clinicaltrials_resource:3f0006d02d5a59956b2eb8fec647fedf]
Bio2RDF identifier
3f0006d02d5a59956b2eb8fec647fedf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3f0006d02d5a59956b2eb8fec647fedf
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
maximum age [clinicaltrials_vocabulary:maximum-age]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
DISEASE CHARACTERISTICS: Hodgk ...... on or IV fluids posttransplant
identifier
clinicaltrials_resource:3f0006d02d5a59956b2eb8fec647fedf
title
eligibility for clinicaltrials:NCT00005993
@en
type
label
eligibility for clinicaltrials ...... 006d02d5a59956b2eb8fec647fedf]
@en